Tech Company Financing Transactions
Reset Therapeutics Funding Round
Reset Therapeutics closed a $14.8 million funding round on 12/5/2013. Backers included private investors.
Transaction Overview
Company Name
Announced On
12/5/2013
Transaction Type
Venture Equity
Amount
$14,796,231
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
260 Littlefield Ave. 200
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Reset Therapeutics is focused on harnessing the power of the body's internal molecular clocks to discover, develop, and commercialize high-value therapeutics for a variety of disease indications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ross Bersot
VP - Finance
Shu Kurosaki
Browse more venture capital transactions:
Prev: 12/5/2013: Green Biologics venture capital transaction
Next: 12/5/2013: Glassdoor venture capital transaction
Share this article
Where The Data Comes From
We report on funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs